Clinical Trial Update: Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating the safety and efficacy of OCU200 for center-involved diabetic macular edema, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• OCU200

Snippet

Sponsor: Ocugen | Conditions: Center Involved Diabetic Macular Edema, Diabetic Macular Edema | Phase 1 | Status: RECRUITING